Sonnet BioTherapeutics Holdings Inc. has announced its upcoming Annual Meeting of Stockholders. The meeting will focus on several key proposals, including the election of five directors to the Board for the following year until their successors are elected, and the approval of the executive compensation of the Named Executive Officers. The meeting aims to secure the stockholders' approval on these matters.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonnet Biotherapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-025558), on August 26, 2025, and is solely responsible for the information contained therein.